News about Lymphoma

Sílvia Beà, winner of the CIBERONC “Award for Best Female Researcher”

Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, with1

Clínic Barcelona

Research November 4 2020

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1

Clínic Barcelona

Health Topics July 2 2020

Coronavirus has a more serious impact on patients with haematological diseases

People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1

Clínic Barcelona

Health Topics December 13 2019

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1

Clínic Barcelona

Health Topics July 5 2019

Evolution of cancer immunotherapy: from bone marrow transplant to CAR

The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining th1

2 2

page1
page2 , current page.

News about Lymphoma

Sílvia Beà, winner of the CIBERONC “Award for Best Female Researcher”

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

Coronavirus has a more serious impact on patients with haematological diseases

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

Evolution of cancer immunotherapy: from bone marrow transplant to CAR

navigation between pages below

Subscribe to the Newsletter of Clínic